These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6580479

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
    Balzarini J, De Clercq E.
    Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514
    [Abstract] [Full Text] [Related]

  • 4. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J, Cooney DA, Dalal M, Kang GJ, Cupp JE, DeClercq E, Broder S, Johns DG.
    Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
    Boothman DA, Briggle TV, Greer S.
    Cancer Res; 1987 May 01; 47(9):2344-53. PubMed ID: 2436761
    [Abstract] [Full Text] [Related]

  • 7. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
    Momparler RL, Veselý J, Momparler LF, Rivard GE.
    Cancer Res; 1979 Oct 01; 39(10):3822-7. PubMed ID: 476619
    [Abstract] [Full Text] [Related]

  • 8. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR, Campbell J, Rustum YM.
    Cancer Treat Rep; 1983 Jun 01; 67(6):547-54. PubMed ID: 6190558
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
    Samuels LL, Straw JA.
    Cancer Res; 1984 Jun 01; 44(6):2278-84. PubMed ID: 6609764
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice.
    Veselý J, Cihák A.
    Cancer Res; 1977 Oct 01; 37(10):3684-9. PubMed ID: 71199
    [Abstract] [Full Text] [Related]

  • 15. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes.
    Keszler G, Szikla K, Kazimierczuk Z, Spasokoukotskaja T, Sasvari-Szekely M, Staub M.
    Biochem Pharmacol; 2003 Feb 15; 65(4):563-71. PubMed ID: 12566083
    [Abstract] [Full Text] [Related]

  • 16. Reversible permeabilization of lymphocytes destroys the incorporation of deoxythymidine but not of deoxycytidine.
    Taljanidisz J, Sasvari-Szekely M, Spasokutotskaja T, Antoni F, Staub M.
    Biochim Biophys Acta; 1986 Mar 14; 885(3):266-71. PubMed ID: 3947681
    [Abstract] [Full Text] [Related]

  • 17. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
    Santelli G, Valeriote F.
    J Natl Cancer Inst; 1978 Sep 14; 61(3):843-7. PubMed ID: 278862
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.